secwatch.observer — SEC 8-K summary
======================================

Issuer:     HERON THERAPEUTICS, INC. /DE/ (HRTX)
CIK:        0000818033
Form:       8-K
Filed at:   2026-06-25T21:00:14+00:00
Accession:  0001193125-26-282988
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Heron Therapeutics receives Nasdaq notice for bid price below $1.00; 180 days to cure
--------------------------------------------------------------------------------

- On June 25, 2026, Nasdaq notified Heron that its common stock closing bid price was below $1.00 for 30 consecutive trading days (May 12–June 24, 2026).
- Company has 180 calendar days, until December 22, 2026, to regain compliance by maintaining bid price ≥ $1.00 for at least 10 consecutive days.
- If not cured, Heron may be eligible for an additional 180-day period if it meets other listing standards and notifies Nasdaq of intent to cure via reverse stock split.
- There is no immediate impact on trading; shares continue to trade under HRTX on Nasdaq Capital Market.
- Company intends to monitor share price and explore options to regain compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/818033/000119312526282988/0001193125-26-282988-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/818033/000119312526282988/hrtx-20260625.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-282988

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer